跳至主要内容
临床试验/NCT03236051
NCT03236051Unknown不适用

Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center Study

JIANG Zhi-Wei2 个研究点 分布在 1 个国家目标入组 156 人开始时间: 2017年2月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
156
试验地点
2
主要终点
Numeric rating scales (NRS) score with 24 hours after the surgery

研究概览

简要总结

The study is aimed to explore the effects of multimodal analgesia consisting of ropivacaine's wound infiltration, parecoxib's intravenous injection and oxycodone-acetaminophen tablets' oral administration on postoperative pain and rehabilitation after laparoscopic radical gastrectomy for patients with gastric cancer.

详细描述

Postoperative pain attracts the attention of surgeons, and optimal postoperative pain management contributes to reducing complications and accelerating postoperative rehabilitation. Traditionally, the opioids were used for postoperative pain control. However, the opioids may increase the time to recover bowel function and lead to postoperative ileus. Multimodal analgesia is recommended in recent years, but studies on multimodal analgesia after gastrectomy are scarce. In this study, we introduced a multimodal analgesia strategy consisting of incision infiltration with ropivacaine, intravenous injection of parecoxib, and oral administration of an oxycodone/paracetamol mixture and evaluated the effects of this strategy compared with PCIA analgesia which is used widely for pain after gastrectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Requirements of informed consent and assent of participant, parent or legal guardian as applicable.
  • Patients underwent laparoscopic radical gastrectomy under general anesthesia and between the age of 18 and 75 years old without considering sex.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Participants can follow the drug doses and visit plan

排除标准

  • Patients certified by a doctor that doesn't fit to participate in this study.
  • Patients allergic to opioids, sulfas, parecoxib, non-steroidal drugs, acetaminophen, tramadol etc..
  • Patients with ischemic heart disease, cerebrovascular disease and peripheral vascular disease, or their cardiac function > II (NYHA) patients, patients received coronary artery bypass grafting (CABG) recently, and patients with severe hypertension (systolic pressure≥180mmHg or diastolic pressure≥110mmHg).
  • Patients with gastric cancer with distant metastasis.
  • Patients with severe infection, respiratory dysfunction, coagulation disorders, severe liver and renal dysfunction (Child - Pugh≥ 10; creatinine clearance < 25 ml/min).
  • Patients with suspect or have a history of drug abuse.
  • Pregnancy and lactation women, or have a pregnancy plan within a month after the test of the subjects (also including male participants).
  • Sponsors or researchers directly involved in the testing or their family members.
  • Patients with conversion, palliative resection.
  • Patients with chronic pain(NRS≥3)or using opioids or NSAIDs before surgery.

研究组 & 干预措施

multimodal analgesia

Experimental

Patients received multimodal analgesia after laparoscopic gastrectomy .

干预措施: Multimodal analgesia (Procedure)

PCIA analgesia

Active Comparator

Patients received PCIA analgesia after laparoscopic gastrectomy.

干预措施: PCIA analgesia (Procedure)

结局指标

主要结局

Numeric rating scales (NRS) score with 24 hours after the surgery

时间窗: 1 day

pain evaluation

次要结局

  • NRS score after 24 hours postoperatively(1 week)
  • Total protein(1 year)
  • Number of remedial treatment(1 week)
  • Time to first off-bed activity(1 week)
  • interleukin-6 (IL-6)(1 week)
  • Albumin(1 year)
  • Prealbumin(1 year)
  • Length of off-bed activity per day(1 week)
  • Time to first flatus(1 week)
  • Time to first semi-liquid diet(1 week)
  • Postoperative length of stay(1 month)
  • C-reactive protein (CRP)(1 week)
  • Time of off-bed activity per day(1 week)

研究者

发起方
JIANG Zhi-Wei
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

JIANG Zhi-Wei

Vice director of Research Institute of General Surgery

Jinling Hospital, China

研究点 (2)

Loading locations...

相似试验